Oncolys BioPharma Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1,352	2,166	1,288	1,466	3,210	1,823
Short-Term Investments	-	245.08	245.08	245.08	245.08	245.08
Cash & Short-Term Investments	1,352	2,411	1,533	1,711	3,455	2,068
Cash Growth	-17.72%	57.29%	-10.43%	-50.47%	67.06%	-38.13%
Accounts Receivable	29.76	-	-	-	352.15	70.6
Other Receivables	272.37	148.25	101.75	278.59	24.48	96.99
Receivables	346.77	148.25	101.75	318.4	376.63	167.59
Inventory	3.82	4.58	5.34	24.25	11.66	10.47
Prepaid Expenses	75.12	53.45	33.34	47.97	120.98	241.38
Other Current Assets	334.33	480.97	282.61	506.85	234.03	58.31
Total Current Assets	2,112	3,098	1,956	2,609	4,198	2,546
Property, Plant & Equipment	2.88	-	-	-	-	21.32
Long-Term Investments	21.04	21.04	21.04	21.04	21.04	112.47
Other Intangible Assets	-	-	-	-	-	0.65
Other Long-Term Assets	52.52	32.13	21.13	21.17	38.33	85.25
Total Assets	2,188	3,199	2,041	2,651	4,292	2,796
Accounts Payable	39.89	52.29	193.35	60.86	106.25	206.61
Accrued Expenses	18.71	20.45	19.12	17.1	16.85	15.33
Short-Term Debt	238.89	127.78	127.78	227.78	238.88	150.01
Current Portion of Leases	10.28	10.18	7.57	3.58	2.67	2.14
Current Income Taxes Payable	-	31.89	18.84	2.93	59.24	33.49
Other Current Liabilities	11.13	9.81	11.87	9.39	6.32	7.66
Total Current Liabilities	318.89	252.39	378.53	321.64	430.21	415.24
Long-Term Debt	77.77	166.66	161.1	155.54	255.54	366.65
Long-Term Leases	12.31	20.03	18.73	6.76	6.37	6.28
Pension & Post-Retirement Benefits	8.59	7.57	8.14	7.75	5.76	4.92
Other Long-Term Liabilities	0	0	0	0	0	0
Total Liabilities	417.56	446.65	566.5	491.69	697.88	793.09
Common Stock	3,015	5,108	3,623	3,000	9,040	7,437
Additional Paid-In Capital	333.41	2,694	1,210	586.43	9,064	7,461
Retained Earnings	-1,617	-5,058	-3,373	-1,435	-14,517	-12,901
Treasury Stock	-0.02	-0.14	-0.14	-0.14	-0.11	-0.08
Comprehensive Income & Other	39.19	7.68	14.68	7.68	7.68	7.5
Shareholders' Equity	1,771	2,752	1,474	2,159	3,594	2,003
Total Liabilities & Equity	2,188	3,199	2,041	2,651	4,292	2,796
Total Debt	339.24	324.64	315.17	393.66	503.47	525.08
Net Cash (Debt)	1,013	2,086	1,218	1,318	2,951	1,543
Net Cash Growth	-22.84%	71.34%	-7.58%	-55.35%	91.29%	-45.18%
Net Cash Per Share	40.68	95.57	68.42	76.04	174.47	107.20
Filing Date Shares Outstanding	25.85	24.86	19.72	17.32	17.34	14.63
Total Common Shares Outstanding	25.85	24.86	19.63	17.32	17.34	14.63
Working Capital	1,793	2,846	1,577	2,287	3,768	2,130
Book Value Per Share	68.51	110.71	75.10	124.65	207.31	136.96
Tangible Book Value	1,771	2,752	1,474	2,159	3,594	2,003
Tangible Book Value Per Share	68.51	110.71	75.10	124.65	207.31	136.91
Buildings	5.95	3.13	3.13	2.79	2.79	2.79
Machinery	45.18	68.71	67.89	65.94	65.02	87.53

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.